As reported in IVC: Collaboration will combine Haifa’s know-how in advanced diagnostics and Lithuanian experience in clinical methodology.
IBM’s R&D centers in Israel, Switzerland and the US will help the Lithuanian government set up an R&D center. The joint research partnership between IBM and the Lithuanian government will focus on healthcare, nanotechnology and IP management.
According to the collaborative agreement signed between IBM and the Lithuanian government, the Baltic state’s leading universities and hospitals will cooperate with the company’s R&D centers in Haifa, Zurich, New York and San Jose.
In particular, researchers from Haifa’s lab will partner with Lithuanian scientists on a variety of healthcare projects that will aim to provide a better understanding of how to diagnose, and treat life-threatening diseases, such as cardiovascular disease and blood disorders. The research collaborations will take advantage of Haifa’s know-how in advanced diagnostics and Lithuanian experience in clinical methodology for improving treatment of patients and checking effectiveness in the field.